Eisaku Iwanaga
Kumamoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Fulminant Clostridioides difficile Infection During Repeated High-Dose Cytarabine Consolidation for Acute Myeloid Leukemia: A Fatal Case.
Journal: Cureus
Published: January 23, 2026
Development of a blood test-based predictive scoring tool for treatment response in chronic myeloid leukemia.
Journal: International journal of hematology
Published: September 03, 2025
The incidence of vascular adverse events and usefulness of novel risk assessment tool in Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.
Journal: Cardio-oncology (London, England)
Published: February 13, 2025
Antibiotic spectrum coverage scoring as a potential metric for evaluating the antimicrobial stewardship team activity: a single-center study.
Journal: Infection control and hospital epidemiology
Published: October 10, 2024
Investigating the WHO's AWaRe classification for assessing antimicrobial stewardship programs: A single-center study.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: July 08, 2024
Changes in chronic myeloid leukemia treatment modalities and outcomes after introduction of second-generation tyrosine kinase inhibitors as first-line therapy: a multi-institutional retrospective study by the CML Cooperative Study Group.
Journal: International journal of hematology
Published: October 19, 2023
Management and Risk Factors for Pleural Effusion in Japanese Patients with Chronic Myeloid Leukemia Treated with First-line Dasatinib in Real-world Clinical Practice.
Journal: Internal medicine (Tokyo, Japan)
Published: April 02, 2023
Clinical management of second-generation tyrosine kinase inhibitor therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase, focusing on age and dose effects.
Journal: International journal of hematology
Published: February 03, 2023
Dissecting the cell of origin of aberrant SALL4 expression in myelodysplastic syndrome.
Journal: Clinical and translational medicine
Published: January 19, 2023
Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitors.
Journal: Annals of medicine
Published: April 29, 2022
Core-binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis.
Journal: Blood
Published: February 08, 2022
A regulatory element in the 3'-untranslated region of CEBPA is associated with myeloid/NK/T-cell leukemia.
Journal: European journal of haematology
Published: October 14, 2020
Last Updated: 09/26/2026